Interestingly, metabolic rewiring in response to MEK inhibition has been previously described as a possible mechanism of resistance in melanoma cells (Ruocco et al. 2019; Nguyen et al. 2020), and targeting of lipid metabolism has been previously reported in ovarian cancer cells (Chen et al. 2019). Here, MAP2K7 is linked to ovarian carcinoma.